Itamar Medical (ITMR) Stock Price, News & Analysis

Company Overview

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Key Stats

• Today's Range: $30.87 to $30.87
• 50-Day Range: $30.54 to $30.87
• 52-Week Range: $16.36 to $30.91
• Volume: N/A
• Average Volume: 90,796 shs
• Market Capitalization: $497.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ITMR Stock Analysis - Frequently Asked Questions

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) posted its earnings results on Thursday, November, 18th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.32. The firm earned $13.57 million during the quarter, compared to the consensus estimate of $13.70 million.

Does Itamar Medical have any subsidiaries?

Itamar Medical subsidiaries include I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Itamar Medical investors own include AbbVie (ABBV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Gilead Sciences (GILD), Cheniere Energy (LNG), M&T Bank (MTB) and Energy Transfer (ET).

Company Calendar

• Last Earnings: 11/18/2021
• Today: 5/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ITMR
• CIK: 1613170
• Web: www.itamar-medical.com
• Phone: (724) 617-7000
• Fax: N/A
• Employees: 257
• Year Founded: 1997

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $41.03 million
• Price / Sales: 12.12
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 16,108,000
• Free Float: N/A
• Market Cap: $497.25 million
• Optionable: Not Optionable
• Beta: 0.73